Cargando…
Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
Autores principales: | Lanzi, Cinzia, Yates, Edwin Alexander, Cassinelli, Giuliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047317/ https://www.ncbi.nlm.nih.gov/pubmed/32154182 http://dx.doi.org/10.3389/fonc.2020.00195 |
Ejemplares similares
-
Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
por: Lanzi, Cinzia, et al.
Publicado: (2018) -
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer
por: Furini, Simone, et al.
Publicado: (2021) -
Heparan Sulfate Proteoglycans as Emerging Players in Synaptic Specificity
por: Condomitti, Giuseppe, et al.
Publicado: (2018) -
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity
por: Brunetti, Jlenia, et al.
Publicado: (2019) -
Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan
por: Elgundi, Zehra, et al.
Publicado: (2020)